Get started

Moderna

ridethepig | Long $ABUS for an 80% move...Another single stock opportunity that is worth building a bridge over; $ABUS (Arbutus Biopharma) an excellent and cheap shelter for the next chapter in covid flows. The beauty of choice! It is interesting as all covid vaccines will have to RNA IP .. this is a convincing driver. As well as creating a shelter, use the intimately linked highs to add and build more on the position once it starts working. I am looking for an +80% move to the upside over the coming weeks. Thanks as usual for keeping the feedback coming 👍 or 👎
NASDAQ:ABUSLong
by ridethepig
5
Will Moderna save the world ?We don't know if the hype is over around MRNA. It has probably finished its 5-wave impulse and will need to settle down in correction. There is support zone in the range 87-103 formed by previous price highs and some Fibo levels as seen on the chart. From the fundamental point of view we could compare Moderna with some other biotechs: AMGN, GILD, VRTX, REGN, ILMN, BIIB. Their P/S ratios (Price to Sale) are in the range from 3.50 to 14.50. Big names like GSK, PFE, MRK make 5-7bn in all vaccine sales per year. If MRNA makes $2bn in sales, at P/S=15 their Market Cap should be around $30bn --> $77 per share.
NASDAQ:MRNA
by ProTrading24ru
8
Moderna says they have a vaccine, ask for emergency approvalModerna announced today it would request the United States & Europe an emergency authorization for their vaccine. If my sources are correct. As usual most of the mainstream media are unable to relay the information correctly, according to them the demand has already been made some posted at the same time say "will", and some only mention the FDA (the US one). From their own site: "FDA has told Company to expect VRBPAC meeting for mRNA-1273 likely on December 17, 2020" investors.modernatx.com The FDA is the very competent very legit administration that authorized the Redemsivir after all of the final results (showing how bad it was) had been published, reviewed, circulated... "These risks, uncertainties, and other factors include, among others: the fact that there has never been a commercial product utilizing mRNA technology approved for use; the fact that the rapid response technology in use by Moderna is still being developed and implemented; the safety, tolerability and efficacy profile of mRNA-1273 observed to date may change adversely in ongoing analyses of trial data or subsequent to commercialization; " "In some cases, forward-looking statements can be identified by terminology such as “will,” “may,” “should,” “could”, “expects,” “intends,” “plans,” “aims,” “anticipates,” “believes,” “estimates,” “predicts,” “potential,” “continue,” or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. The forward-looking statements in this press release are neither promises nor guarantees " Sell hype, but hey, make sure you are covered. The price gapped by 13%, went up 4% 2 minutes after the announcement, is up 50% in the last 3 days. Moderna investor news release is 50 lines long. Investors of course also read the latest 10Q published the 30 October available here and 400 pages long: investors.modernatx.com Impressive! These investors are very fast readers! "We are expending significant efforts to further the rapid development of this potential vaccine and expect to continue to do so over the next 12 months." Authorized and distributed by december? 12 months? Distributed, maybe obligatory, still in development? These words should not be in the same sentence. Hey maybe I am just a plebe and it is typical for this to happen, I really need a medical advisor at some point. Dad! He sells pills and vaccines for big pharma, perfect candidate. If (jk there is no if) - When I get rich I will need advisors in all areas I just cannot deal with that much info and misinformation, and correlations, and risks, and so on. Hey and rich people will be able to afford real science and real medical treatments while the plebes get the untested vaccines with coinflip long term effects. They are turning healthcare into a consumer thing, it is not about healing the sick but distributing (for a cost) supplements and medications and prevention vaccines to everybody. I do not know if this will, or can, continue. Medical doctors are against (I think) turning the population into drugged zombies. The sheep well I am not sure about the sheep, I think the "silent majority" just obeys and follows no matter what - this is what they have done for all of history. If they make progress to sell products to make people that go into old age have better quality years then it could work out but still not sure because those that cannot afford it are not going to accept this, people see healthcare (at least today) as a basic human right. Anyway let the fomoers and gamblers fomo and gamble, I strongly think this is very very early, and the worse the greedy corporations and their liberal-bourgeois buddies in governments behave (how they handle this vaccine for example), the longer it will take for people to forget and the biotech bull market / revolution to comeback and go up. People have goldfish memories so it won't take an entire lifetime either, 5 to 20 years to complete a bear market then start an uptrend. Well too many variables, we will see later, for now we observe and wait. Let's see what happens with this new tech.
NASDAQ:MRNA
by MrRenev
MODERNA MRNA Trend Analysis Shows Time To InvestRight now, stocks in companies developing a vaccine against the virus look very attractive to investors. Knowing how to correctly determine the trend and price movement, you can make a profitable investment and get a lot of profit. We have developed a script that analyzes price movements in real time, taking into account current and past trends, and offers signals to buy company shares MODERNA NASDAQ:MRNA . The script is developed on the basis of the following indicators: Bollinger Bands and Moving Average, Supertrend indicator. Signals are trending and will help complement your trading strategy and more accurately determine entry points. This idea is useful for intraday traders timeframes 1H, 2H, 4H.
NASDAQ:MRNA
by atmospherestockstrade
MRNA Moderna vaccine 94.5% effective in Phase 3 trial!This was my previews post about Moderna: The indicators are still bullish. The price of the stock grew 5X since the beginning of the year. 11/16/2020 Oppenheimer Boost Price Target ➝ $157.00 11/16/2020 Piper Sandler Boost Price Target ➝ $166.00 The traditional method of creating vaccines – introducing a weakened or dead virus, or a piece of one, to stimulate the body's immune system – takes over a decade on average, according to a 2013 study. One pandemic flu vaccine took over eight years while a hepatitis B vaccine was nearly 18 years in the making. Moderna's vaccine went from gene sequencing to the first human injection in 63 days. Moderna and BioNTech, for example, are also applying mRNA technology to experimental cancer medicines. BioNTech's vaccine, for example, must be transported at minus 70 degrees Celsius, though Moderna said on Monday it can ship its candidate in normal refrigerators. (Reuters) If you are interested to test some amazing BUY and SELL INDICATORS, which give the signal at the beginning of the candle, not at the end of it, just leave me a message.
NASDAQ:MRNALong
by TopgOptions
My two cents on my most profitable traded stock this year, MRNAI have traded MRNA more than any other stock. Even if you lack the experience and know-how of trading, following some basics trends will give you a high winning percentage with this stock. 1) Finding the premarket high and shorting the stock close to that gives you about an 85% chance of a 50cent-$1 move before market opens. 2) A lot of the news on this stock is old and reused. Today for example there is news that seniors exhibit very few health issues with the stock. This is old news. 3) With every single run up including the first major one close to $100 a few months back, MRNA has flushed 100% of the time with no ability to maintain the premarket levels.
NASDAQ:MRNAShort
by cazmuh